1 |
Coulon C, Collignon A, McDonnell G, Thomas V. Resistance of Acanthamoeba cysts to disinfection treatments used in health care settings. J Clin Microbiol. 2010. 48: 2689-2697.
DOI
ScienceOn
|
2 |
Ficker L. Acanthamoeba keratitis--the quest for a better prognosis. Eye 1988. 2: 37-45.
|
3 |
Marciano-Cabral F, Cabral G. Acanthamoeba spp. as agents of disease in humans. Clin Microbiol Rev. 2003. 16: 273-307.
DOI
ScienceOn
|
4 |
Naginton J, Watson PG, Playfair TJ, McGill J, Jones BR, Steele AD. Amoebic infection of the eye. Lancet 1974. 2: 1537-1540.
|
5 |
Seal DV. Acanthamoeba keratitis update-incidence, molecular epidemiology and new drugs for treatment. Eye 2003. 17: 893-905.
DOI
ScienceOn
|
6 |
Stehr-Green JK, Bailey TM, Visvesvara GS. The epidemiology of Acanthamoeba keratitis in the United States. Am J Ophthalmol. 1989. 107: 331-336.
|
7 |
Yu HS, Kong HH, Kim SY, Hahn YH, Hahn TW, Chung DI. Laboratory investigation of Acanthamoeba lugdunensis from patients with keratitis. 2004. Invest Ophthalmol Vis Sci. 45: 1418-1426.
DOI
ScienceOn
|